Age-related macular degeneration has a devastating effect on quality of life.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Ophthalmology and OptometryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target.Retina. 2017; 37: 819
- The progression of geographic atrophy secondary to age-related macular degeneration.Ophthalmology. 2017; 125: 369-390
- New treatment modalities for geographic atrophy.Asia Pac J Ophthalmol (Phila). 2017; 6: 508-513
- Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects.Clin Ophthalmol. 2015; 9: 2159
- Complement factor D in age-related macular degeneration.Invest Ophthalmol Vis Sci. 2011; 52: 8828-8834
- Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage.Invest Ophthalmol Vis Sci. 2007; 48: 5282-5289
- A review of current and future management of geographic atrophy.Ophthalmol Ther. 2017; 6: 69-77
- Age-related macular degeneration foils drugmakers.Nat Biotechnol. 2017; 35: 1000-1001
- Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements.Artif Cells Nanomed Biotechnol. 2017; : 1-14https://doi.org/10.1080/21691401.2017
- Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration.Proc Natl Acad Sci U S A. 2011; 108: 6241-6245
- Update on clinical trials in dry age-related macular degeneration.Middle East Afr J Ophthalmol. 2016; 23: 13
- Phase II, randomized, placebo-controlled, 90-day study of emixustat HCl in geographic atrophy associated with dry age-related macular degeneration.Retina. 2015; 35: 1173
- Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration.Retina. 2013; 33: 498-507
- Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration.J neuroinflammation. 2015; 12: 209
- Reduced foveolar choroidal blood flow in eyes with increasing AMD severity.Invest Ophthalmol Vis Sci. 2005; 46: 1033-1038
- Randomized clinical trial France DMLA2: effect of trimetazidine on exudative and nonexudative age-related macular degeneration.Retina. 2012; 32: 834-843
- Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial.Expert Opin Investig Drugs. 2013; 22: 803-812
- Holz F.G. Pauleikhoff D. Spaide R.F. Age-related macular degeneration. Springer Science & Business Media, Berlin/Heidelberg (Germany)2012
- Effect of Viagra on the foveolar choroidal circulation of AMD patients.Exp Eye Res. 2005; 81: 159-164
- Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.Cochrane Database Syst Rev. 2009; (CD006537)
- Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives.Graefes Arch Clin Exp Ophthalmol. 2017; 256: 1-9
- Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study.Am J Ophthalmol. 2006; 141: 276-281
- Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.Ophthalmology. 2006; 113: 1974-1986
- Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.Cochrane Database Syst Rev. 2015; (CD006537)
- Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: a pilot study functionally guided retinal protective therapy.Invest Ophthalmol Vis Sci. 2016; 57: 265-275
- Subthreshold nanosecond laser intervention in intermediate age-related macular degeneration: study design and baseline characteristics of the laser in early stages of age-related macular degeneration study (report number 1).Ophthalmol Retina. 2017; 1: 227-239
- Microcurrent stimulation in the treatment of dry and wet macular degeneration.Clin Ophthalmol. 2015; 9: 2345
- Embryonic stem cell trials for macular degeneration: a preliminary report.Lancet. 2012; 379: 713-720
- Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration.Clin Ophthalmol. 2015; 9: 1099
Article info
Footnotes
Disclosure: The authors have nothing to disclose.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
